Intuitive Surgical price target raised to $622 from $561 at BTIG
BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after its Q4 earnings beat. The company’s System sales and procedure growth Y/Y meaningfully exceeded the Street’s high expectations by 58 units and 170bps respectively,
Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note ...
BTIG analyst Vincent Caintic maintained a Hold rating on Bread Financial Holdings (BFH – Research Report) today. The company’s shares closed ...
BTIG Chief Market Technician Jonathan Krinsky thinks the market can “continue to make upside progress” into year-end and sees a new all-time high for the S&P 500 (SPX) above 6,100. However ...
What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...
Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual MedTech, Digital Health, Life Science ...
Deckers Outdoor stock falls 14% as raised guidance falls short of expectations, facing headwinds from strong dollar and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback